Search for: "Watson Pharma"
Results 121 - 140
of 184
Sorted by Relevance
|
Sort by Date
18 Apr 2012, 9:48 pm
Bayer Schering Pharma et al. v. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
2 Jun 2017, 3:06 am
Thomas Watson, Robert H. [read post]
27 Apr 2010, 10:58 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
11 Nov 2009, 4:02 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Dec 2009, 3:59 pm
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 Mar 2010, 2:30 am
Astellas Pharma US, Inc. [read post]
16 Nov 2012, 2:30 am
The defendants in their case include Watson Laboratories Inc., Actavis Elizabeth LLC and Pliva Inc., manufacturers of the generic equivalent of Reglan, as well as Schwartz Pharma. [read post]
3 Jan 2011, 9:55 pm
Takeda has granted Mylan, Watson, and Ranbaxy licenses to enter the U.S. market with generic Actos on August 17, 2012, subject... [read post]
29 Jul 2009, 6:45 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 Dec 2009, 9:59 am
Watson Laboratories, Inc.- Florida, Watson Pharma Inc. and Watson Pharmaceuticals Inc. [read post]
12 Mar 2009, 8:23 am
Guests: Andrew Watson, ipVA: Intellectual Property strategy and advisory consultants Stephen Albainy-Jenei, Patent Baristas: Freshly brewed Bio/Pharma chat. [read post]
30 Dec 2016, 7:38 am
" Bayer Pharma AG et al v. [read post]
18 Jun 2013, 10:24 am
In this case, the Supreme Court considered an arrangement by which brand firm Solvay paid generics Watson (now Actavis) and Paddock roughly $30 to $40 million to delay entering the market with generic versions of testosterone gel. [read post]
5 Apr 2017, 7:53 am
Noven Pharma (Fed. [read post]
12 Dec 2006, 9:56 pm
Sheridan granted Savient's request for temporary relief, ordering Sandoz and Upsher-Smith to stop efforts to market their generic products and ordering Savient to ensure that Watson Labs would not launch an authorized generic of Oxandrin. [read post]
3 Apr 2009, 4:50 am
(IPKat) US: Third follow-on biologics bill, Promoting Innovation and Access to Life-Saving Medicine Act in 111th Congress; draws industry ire (Patent Docs) (Law360) US: CAFC: Anticipation of genus by prior art species in long list: In re Gleave (Hal Wegner) (Patent Docs) US: Life Technologies, General Electric settle patent suit over DNA amplification kits (Law360) Products Concerta (Methylphenidate) – US: Delaware court rules Watson does not infringe patent related to… [read post]
2 Apr 2007, 9:52 pm
Synthon, Watson Caduet: Pfizer v. [read post]
17 Jul 2014, 10:58 am
.; Aurobindo Pharma Limited; Aurobindo Pharma USA Inc.; Dr. [read post]
17 Mar 2014, 11:03 am
.; Aurobindo Pharma Limited; Aurobindo Pharma USA Inc.; Dr. [read post]
